Skip to main content

Advertisement

Log in

Common variable immunodeficiency-associated myelitis

Report of treatment with infliximab

  • LETTER TO THE EDITORS
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cunningham-Rundles C, Bodian C (1999) Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 92:34–48

    Article  CAS  PubMed  Google Scholar 

  2. Weiler CR, Bankers-Fulbright JL (2005) Common variable immunodeficiency: test indications and interpretations. Mayo Clin Proc 80:1187–1200

    Article  CAS  PubMed  Google Scholar 

  3. Rudge P, Webster AD, Revesz T, Warner T, Espanol T, Cunningham-Rundles C, et al. (1996) Encephalomyelitis in primary hypogammaglobulinaemia. Brain 119:1–15

    Article  PubMed  Google Scholar 

  4. Smith KJ, Skelton H (2001) Common variable immunodeficiency treated with a recombinant human IgG, tumour necrosis factor-alpha receptor fusion protein. Br J Dermatol 144:597–600

    Article  CAS  PubMed  Google Scholar 

  5. Hatab AZ, Ballas ZK (2005) Caseating granulomatous disease in common variable immunodeficiency treated with infliximab. J Allergy Clin Immunol 116:1161–1162

    Article  CAS  PubMed  Google Scholar 

  6. Thatayatikom A, Thatayatikom S, White AJ (2005) Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature. Ann Allergy Asthma Immunol 95:293–300

    Article  PubMed  Google Scholar 

  7. Kilic SS (2005) Anti-tumour necrosis factor-alpha treatment of juvenile idiopathic arthritis in a patient with common variable immunodeficiency. J Trop Pediatr 51:194–195

    Article  PubMed  Google Scholar 

  8. Nos P, Bastida G, Beltran B, Aguas M, Ponce J (2006) Crohn’s disease in common variable immunodeficiency: treatment with antitumor necrosis factor alpha. Am J Gastroenterol 101:2165–2166

    Article  PubMed  Google Scholar 

  9. Lin JH, Liebhaber M, Roberts RL, Dyer Z, Stiehm ER (2006) Etanercept treatment of cutaneous granulomas in common variable immunodeficiency. J Allergy Clin Immunol 117(4):878–882

    Article  CAS  PubMed  Google Scholar 

  10. Medlicott SA, Coderre S, Horne G, Panaccione R (2006) Multimodal immunosuppressant therapy in steroidrefractory common variable immunodeficiency sprue: a case report complicating cytomegalovirus infection. Int J Surg Pathol 14:101–106

    Article  CAS  PubMed  Google Scholar 

  11. Warnatz K, Denz A, Drager R, Braun M, Groth C, Wolff-Vorbeck G, et al. (2002) Severe deficiency of switched memory B cells (CD27(+)IgM(–) IgD(–)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 99:1544–1551

    Article  CAS  PubMed  Google Scholar 

  12. Fasano MB, Sullivan KE, Sarpong SB, Wood RA, Jones SM, Johns CJ, et al. (1996) Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature. Medicine 75:251–261

    Article  CAS  PubMed  Google Scholar 

  13. Mechanic LJ, Dikman S, Cunningham- Rundles C (1997) Granulomatous disease in common variable immunodeficiency. [see comment]. Ann Intern Med 127:613–617

    CAS  PubMed  Google Scholar 

  14. Kanathur N, Byrd RP, Jr., Fields CL, Roy TM (2000) Noncaseating granulomatous disease in common variable immunodeficiency. South Med J 93:631–633

    CAS  PubMed  Google Scholar 

  15. Pierson JC, Camisa C, Lawlor KB, Elston DM (1993) Cutaneous and visceral granulomas in common variable immunodeficiency. Cutis 52:221–222

    CAS  PubMed  Google Scholar 

  16. Torrelo A, Mediero IG, Zambrano A (1995) Caseating cutaneous granulomas in a child with common variable immunodeficiency. Pediatr Dermatol 12:170–173

    Article  CAS  PubMed  Google Scholar 

  17. Aukrust P, Lien E, Kristoffersen AK, Muller F, Haug CJ, Espevik T, et al. (1996) Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency--possible immunologic and clinical consequences. Blood 87:674–681

    CAS  PubMed  Google Scholar 

  18. Ziegner UHM, Kobayashi RH, Cunningham- Rundles C, Espanol T, Fasth A, Huttenlocher A, et al. (2002) Progressive neurodegeneration in patients with primary immunodeficiency disease on IVIG treatment. Clin Immunol 102:19–24

    Article  PubMed  Google Scholar 

  19. Aslam A, Misbah SA, Talbot K, Chapel H (2004) Vitamin E deficiency induced neurological disease in common variable immunodeficiency: two cases and a review of the literature of vitamin E deficiency. Clin Immunol 112:24–29

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. Kumar MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kumar, N., Hagan, J.B., Abraham, R.S. et al. Common variable immunodeficiency-associated myelitis. J Neurol 255, 1821–1824 (2008). https://doi.org/10.1007/s00415-008-0898-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-008-0898-3

Keywords

Navigation